CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 67 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,618,000 | -26.8% | 545,973 | -28.1% | 0.00% | -50.0% |
| Q3 2016 | $7,674,000 | -4.0% | 759,002 | +6.6% | 0.00% | 0.0% |
| Q2 2016 | $7,996,000 | -14.8% | 712,064 | +3.6% | 0.00% | 0.0% |
| Q1 2016 | $9,385,000 | -26.3% | 687,035 | +2.3% | 0.00% | -33.3% |
| Q4 2015 | $12,735,000 | -5.3% | 671,334 | -6.3% | 0.00% | 0.0% |
| Q3 2015 | $13,447,000 | +31.1% | 716,418 | +4.0% | 0.00% | +50.0% |
| Q2 2015 | $10,259,000 | +171.3% | 688,981 | +176.0% | 0.00% | +100.0% |
| Q1 2015 | $3,781,000 | +21.9% | 249,650 | +7.2% | 0.00% | 0.0% |
| Q4 2014 | $3,102,000 | +1208.9% | 232,904 | +1139.8% | 0.00% | – |
| Q3 2014 | $237,000 | +16.7% | 18,786 | -6.8% | 0.00% | – |
| Q2 2014 | $203,000 | -91.7% | 20,146 | -89.0% | 0.00% | -100.0% |
| Q1 2014 | $2,457,000 | – | 182,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |